Unknown

Dataset Information

0

Correlating SFTPC gene variants to interstitial lung disease in Egyptian children.


ABSTRACT:

Background

Interstitial lung disease (ILD) is a broad heterogeneous group of lung disorders that is characterized by inflammation of the lungs. Surfactant dysfunction disorders are a rare form of ILD diseases that result from mutations in surfactant protein C gene (SFTPC) with prevalence of approximately 1/1.7 million births. SFTPC patients are presented with clinical manifestations of ILD ranging from fatal respiratory failure of newborn to chronic respiratory problems in children. In the current study, we aimed to investigate the spectrum of SFTPC genetic variants as well as the correlation of the SFTPC gene mutations with ILD disease in twenty unrelated Egyptian children with diffuse lung disease and suspected surfactant dysfunction using Sanger sequencing.

Results

Sequencing of SFTPC gene revealed five variants: c.42+35G>A (IVS1+35G>A) (rs8192340) and c.43-21T>C (IVS1-21T>C) (rs13248346) in intron 1, c.436-8C>G (IVS4-8C>G) (rs2070687) in intron 4, c.413C>A p.T138N (rs4715) in exon 4, and c.557G>Ap.S186N (rs1124) in exon 5.

Conclusion

The present study confirms the association of detecting variants of SFTPC with surfactant dysfunction disorders.

SUBMITTER: Abdel Megeid AK 

PROVIDER: S-EPMC9360361 | biostudies-literature | 2022 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Correlating SFTPC gene variants to interstitial lung disease in Egyptian children.

Abdel Megeid Azza K AK   Refeat Miral M MM   Ashaat Engy A EA   El-Kamah Ghada G   El-Saiedi Sonia A SA   Elfalaki Mona M MM   El Ruby Mona O MO   Amr Khalda S KS  

Journal, genetic engineering & biotechnology 20220808 1


<h4>Background</h4>Interstitial lung disease (ILD) is a broad heterogeneous group of lung disorders that is characterized by inflammation of the lungs. Surfactant dysfunction disorders are a rare form of ILD diseases that result from mutations in surfactant protein C gene (SFTPC) with prevalence of approximately 1/1.7 million births. SFTPC patients are presented with clinical manifestations of ILD ranging from fatal respiratory failure of newborn to chronic respiratory problems in children. In t  ...[more]

Similar Datasets

| S-EPMC4130649 | biostudies-literature
| S-EPMC2851554 | biostudies-other
| S-EPMC9818431 | biostudies-literature
| S-EPMC8432578 | biostudies-literature
| S-EPMC10494175 | biostudies-literature
| S-EPMC3960967 | biostudies-literature
| S-EPMC7142048 | biostudies-literature
| S-EPMC7851163 | biostudies-literature
| S-EPMC4333572 | biostudies-literature
| S-EPMC1090616 | biostudies-literature